Atlas Trials

Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients

Clinical trial NCT03774290 · COMPLETED

Trial details

NCT number
NCT03774290
Sponsor
Palobiofarma SL
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2018-06-01
Primary completion
2020-02-05
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.